Search - tctmd.com

Displaying 481 - 500 of 532

Sort: Relevancy | Date

News Daily News

El Subestudio PARTNER Analiza las Direrencias Ecocardiográficas existentes entre la TAVR y la Cirugía

Caitlin E. Cox

April 26, 2013

Presentation TCTAP 2013

Can We Afford TAVR? Economic Insights from the PARTNER Trial

Presenter: David J. Cohen

April 25, 2013

Presentation

Transcatheter vs. Surgical Aortic Valve Replacement in Severe Aortic Stenosis: Echo Parameters in Cohort A of the PARTNER Trial

Presenter: Rebecca T. Hahn

April 24, 2013

News Daily News

Un Meta Análisis Analiza la Regurgitación Post-TAVR y su Influencia sobre la Mortalidad

April 12, 2013

News Daily News

Small Study Supports Transaortic TAVR as Better Option Than Transapical

Jason Kahn

April 12, 2013

News Daily News

Pequeño estudio apoya TAVR transaórtica como mejor opción que la transapical

Jason Kahn

April 12, 2013

News Daily News

Meta-analysis Looks at Post-TAVR Regurgitation, Influence on Mortality

April 12, 2013

Presentation

Post ACC Wrap-up: PREVAIL and PARTNER II

Presenter: Gregg W. Stone

March 13, 2013

Presentation ACC 2013

Clinical Implications of New Left Bundle Branch Block: Sub-Analysis from The PARTNER Experience

Presenter: Tamim Nazif

March 11, 2013

Presentation ACC 2013

New Data from the PARTNER Non-Randomized Continued Access Registry: Outcomes After Transfemoral Transcatheter Aortic Valve Replacement

Presenter: William F. Fearon

March 11, 2013

Presentation ACC 2013

Impact of Sex on Outcomes Following Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis: Insights From The PARTNER Experience

Presenter: Ajay J. Kirtane

March 11, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

Presentation ACC 2013

A Randomized Evaluation of the SAPIEN XT Transcatheter Valve System in Patients with Aortic Stenosis Who Are Not Candidates for Surgery: PARTNER II, Inoperable Cohort

Presenter: Martin B. Leon

March 09, 2013

News Conference News ACC 2013

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

L.A. McKeown

March 09, 2013

News Daily News

Registro Europeo: Los Dispositivos TAVR revelan Resultados Similares a Corto y Largo Plazo

Caitlin E. Cox

January 16, 2013

News Daily News

Transfemoral—But Not Transapical—TAVR More Cost-Effective Than Surgery

Caitlin E. Cox

November 12, 2012

News Daily News

La TAVR Transfemoral, no la Transapical es Más Rentable que la Cirugía

Caitlin E. Cox

November 12, 2012

Presentation TCT 2012

The Surgeon as "Gatekeeper" and Engaged Partner in TAVR

Presenter: Wilson Szeto

October 26, 2012

Presentation TCT 2012

PARTNER: Prognostic Value of Low Flow in Patients with Severe Aortic Stenosis

Presenter: Howard Herrmann

October 24, 2012

Presentation TCT 2012

PARTNER: Early and Late Outcomes of Transcatheter Valve-in-Valves for Failed Balloon Expandable Transcatheter Aortic Valves

Presenter: Raj Makkar

October 24, 2012

Advertisement

El Subestudio PARTNER Analiza las Direrencias Ecocardiográficas existentes entre la TAVR y la Cirugía

Can We Afford TAVR? Economic Insights from the PARTNER Trial

Transcatheter vs. Surgical Aortic Valve Replacement in Severe Aortic Stenosis: Echo Parameters in Cohort A of the PARTNER Trial

Un Meta Análisis Analiza la Regurgitación Post-TAVR y su Influencia sobre la Mortalidad

Small Study Supports Transaortic TAVR as Better Option Than Transapical

Pequeño estudio apoya TAVR transaórtica como mejor opción que la transapical

Meta-analysis Looks at Post-TAVR Regurgitation, Influence on Mortality

Post ACC Wrap-up: PREVAIL and PARTNER II

Clinical Implications of New Left Bundle Branch Block: Sub-Analysis from The PARTNER Experience

New Data from the PARTNER Non-Randomized Continued Access Registry: Outcomes After Transfemoral Transcatheter Aortic Valve Replacement

Impact of Sex on Outcomes Following Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis: Insights From The PARTNER Experience

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

A Randomized Evaluation of the SAPIEN XT Transcatheter Valve System in Patients with Aortic Stenosis Who Are Not Candidates for Surgery: PARTNER II, Inoperable Cohort

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

Registro Europeo: Los Dispositivos TAVR revelan Resultados Similares a Corto y Largo Plazo

Transfemoral—But Not Transapical—TAVR More Cost-Effective Than Surgery

La TAVR Transfemoral, no la Transapical es Más Rentable que la Cirugía

The Surgeon as "Gatekeeper" and Engaged Partner in TAVR

PARTNER: Prognostic Value of Low Flow in Patients with Severe Aortic Stenosis

PARTNER: Early and Late Outcomes of Transcatheter Valve-in-Valves for Failed Balloon Expandable Transcatheter Aortic Valves

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content